Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 2
1971 2
1972 1
1973 2
1974 4
1975 5
1976 15
1977 13
1978 14
1979 38
1980 38
1981 56
1982 82
1983 105
1984 76
1985 83
1986 84
1987 117
1988 90
1989 94
1990 116
1991 135
1992 142
1993 135
1994 134
1995 186
1996 146
1997 112
1998 154
1999 143
2000 168
2001 142
2002 159
2003 158
2004 177
2005 183
2006 177
2007 200
2008 161
2009 169
2010 230
2011 241
2012 242
2013 269
2014 255
2015 252
2016 259
2017 248
2018 251
2019 254
2020 266
2021 301
2022 280
2023 273
2024 88

Text availability

Article attribute

Article type

Publication date

Search Results

7,084 results

Results by year

Filters applied: . Clear all
Page 1
Levonorgestrel-releasing intra-uterine systems as female contraceptives.
Grandi G, Farulla A, Sileo FG, Facchinetti F. Grandi G, et al. Expert Opin Pharmacother. 2018 May;19(7):677-686. doi: 10.1080/14656566.2018.1462337. Epub 2018 Apr 11. Expert Opin Pharmacother. 2018. PMID: 29637798 Review.
INTRODUCTION: The availability and use of long-acting reversible contraceptives (LARCs), such as levonorgestrel intrauterine systems (LNG-IUSs), have increased in recent times. ...
INTRODUCTION: The availability and use of long-acting reversible contraceptives (LARCs), such as levonorgestrel intrauterine systems …
Levonorgestrel. Clinical pharmacokinetics.
Fotherby K. Fotherby K. Clin Pharmacokinet. 1995 Mar;28(3):203-15. doi: 10.2165/00003088-199528030-00003. Clin Pharmacokinet. 1995. PMID: 7758251 Review.
Published values for the serum concentrations and pharmacokinetic parameters of levonorgestrel after administration of various doses of levonorgestrel alone or with ethinylestradiol are reviewed. ...Sex hormone binding globulin (SHBG) plays an important role in l …
Published values for the serum concentrations and pharmacokinetic parameters of levonorgestrel after administration of various doses …
Low-dose ethinylestradiol/levonorgestrel.
Dando TM, Curran MP. Dando TM, et al. Drugs. 2005;65(16):2299-306; discusion 2307-8. doi: 10.2165/00003495-200565160-00007. Drugs. 2005. PMID: 16266199 Review.
Low-dose ethinylestradiol/levonorgestrel 20 microg/100 microg is a combined oral contraceptive that prevents pregnancy primarily by inhibiting ovulation. ...Ethinylestradiol/levonorgestrel 20 microg/100 microg is well tolerated; adverse events were those commonly as …
Low-dose ethinylestradiol/levonorgestrel 20 microg/100 microg is a combined oral contraceptive that prevents pregnancy primarily by i …
Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years.
Nelson AL. Nelson AL. Expert Rev Clin Pharmacol. 2017 Aug;10(8):833-842. doi: 10.1080/17512433.2017.1341308. Epub 2017 Jun 19. Expert Rev Clin Pharmacol. 2017. PMID: 28617060 Review.
A new five-year low dose, smaller-framed, levonorgestrel-releasing intrauterine contraceptive system (LNG-IUS 12) has been introduced to complement the currently available systems. ...
A new five-year low dose, smaller-framed, levonorgestrel-releasing intrauterine contraceptive system (LNG-IUS 12) has been introduced …
Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia.
Luo L, Luo B, Zheng Y, Zhang H, Li J, Sidell N. Luo L, et al. Cochrane Database Syst Rev. 2013 Jun 5;(6):CD009458. doi: 10.1002/14651858.CD009458.pub2. Cochrane Database Syst Rev. 2013. PMID: 23737032 Updated. Review.
The antiproliferative function of levonorgestrel is thought to reduce the risk of endometrial hyperplasia. OBJECTIVES: To determine the efficacy and safety of the levonorgestrel-releasing intrauterine system in reversing atypical endometrial hyperplasia. ...
The antiproliferative function of levonorgestrel is thought to reduce the risk of endometrial hyperplasia. OBJECTIVES: To determine t …
Levonorgestrel-only dosing strategies for emergency contraception.
Hansen LB, Saseen JJ, Teal SB. Hansen LB, et al. Pharmacotherapy. 2007 Feb;27(2):278-84. doi: 10.1592/phco.27.2.278. Pharmacotherapy. 2007. PMID: 17253917 Review.
The American College of Obstetricians and Gynecologists recommends a single dose of levonorgestrel 1.5 mg for emergency contraception as one option. As another option, they recommend two doses of levonorgestrel 0.75 mg may be effective when taken 12-24 hours apart. …
The American College of Obstetricians and Gynecologists recommends a single dose of levonorgestrel 1.5 mg for emergency contraception …
Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.
Coukell AJ, Balfour JA. Coukell AJ, et al. Drugs. 1998 Jun;55(6):861-87. doi: 10.2165/00003495-199855060-00019. Drugs. 1998. PMID: 9617600 Review.
Levonorgestrel 6-capsule subdermal implants (Norplant) are an effective form of reversible contraception. ...CONCLUSION: Levonorgestrel subdermal implants provide effective long term contraception. ...
Levonorgestrel 6-capsule subdermal implants (Norplant) are an effective form of reversible contraception. ...CONCLUSION: Levonorge …
The levonorgestrel intrauterine system: more than a contraceptive.
Andersson K. Andersson K. Eur J Contracept Reprod Health Care. 2001 Jan;6 Suppl 1:15-22. Eur J Contracept Reprod Health Care. 2001. PMID: 11336429 Review.
The levonorgestrel-releasing intrauterine system (LNG-IUS) consists of a plain Nova-T device with a silastic reservoir attached to the vertical arm. The silastic reservoir is impregnated with levonorgestrel and is covered with a rate-limiting silastic membrane. ...
The levonorgestrel-releasing intrauterine system (LNG-IUS) consists of a plain Nova-T device with a silastic reservoir attached to th …
The Mirena levonorgestrel system.
McGavigan CJ, Cameron IT. McGavigan CJ, et al. Drugs Today (Barc). 2003 Dec;39(12):973-84. doi: 10.1358/dot.2003.39.12.799415. Drugs Today (Barc). 2003. PMID: 14747842 Review.
The levonorgestrel intrauterine system is a safe, efficacious, long-term contraceptive device. ...The precise mechanism of this bleeding is unclear, but it may be related to a direct effect of levonorgestrel on endometrial vascular development. Detailed counseling i …
The levonorgestrel intrauterine system is a safe, efficacious, long-term contraceptive device. ...The precise mechanism of this bleed …
7,084 results

Searches related to "levonorgestrel"